Human Abuse Potential of the New Opioid Analgesic Molecule NKTR-181 Compared with OxycodoneLynn R. Webster, Michael A. Eldon, Jack E. Henningfield et al.|Pain Medicine|2016Cited by 29
Human Abuse Potential of Oral NKTR-181 in Recreational Opioid Users: A Randomized, Double-Blind, Crossover StudyXue Ge, Michael A. Eldon, Suresh Siddhanti et al.|Pain Medicine|2019Cited by 9
OP0195 SELECTIVE EXPANSION OF REGULATORY T-CELLS IN HUMANS BY A NOVEL IL-2 CONJUGATE T-REG STIMULATOR, NKTR-358, BEING DEVELOPED FOR THE TREATMENT OF AUTOIMMUNE DISEASESChristie Fanton, Brian L. Kotzin, Suresh Siddhanti et al.|Annals of the Rheumatic Diseases|2019Cited by 5
THU0054 NKTR-358, A NOVEL IL-2 CONJUGATE, STIMULATES HIGH LEVELS OF REGULATORY T CELLS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUSSuresh Siddhanti, Brian L. Kotzin, Christie Fanton et al.|Annals of the Rheumatic Diseases|2020Cited by 5